Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in children

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 5, 2011, Pages 1090-1092

  Biss, T T ^a   Avery, P J ^b   Walsh, P M ^c   Kamali, F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADOLESCENT; ANTICOAGULATION; BLOOD CLOTTING PARAMETERS; CHILD; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LETTER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TARGET THERAPEUTIC RANGE; TIME IN THERAPEUTIC RANGE; TREATMENT OUTCOME;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; MALE; RISK; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 79955666398     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04248.x     Document Type: Letter

References (13)

1. Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AKC, Julian JA, Mitchell L. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 1999; 94: 3007-14.
2. Newall F, Savoia H, Campbell J, Monagle P. Anticoagulation clinics for children achieve improved warfarin management. Thromb Res 2004; 114: 5-9.
3. Bonduel M, Sciuccati G, Hepner M, Feliu Torres A, Pieroni G, Frontroth JP, Serviddio RM. Acenocoumarol therapy in pediatric patients. J Thromb Haemost 2003; 1: 1740-3.
4. Bradbury MJ, Taylor G, Short P, Williams MD. A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio. Arch Dis Child 2008; 93: 303-6.
5. Bhat D, Upponi A, Rakecha A, Thomson J. Evaluating safety, effectiveness, and user satisfaction of home international normalized ratio monitoring service: experience from a tertiary pediatric cardiology unit in the United Kingdom. Pediatr Cardiol 2010; 31: 18-21.
6. ™S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-93.
7. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications for oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-8.
8. Rosendaal F, Cannegieter S, van der Meer F, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
9. Bauman ME, Black K, Kuhle S. KIDCLOT©: the importance of validated educational intervention for optimal long term warfarin management in children. Thromb Res 2009; 123: 707-9.
10. Bauman ME, Black K, Bauman ML, Bruce AAK, Kuhle S, Bajzar L, Massicotte MP. EMPoWarMENT: edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease. Thromb Res 2010; 126: e110-5.
11. Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis 2003; 15: 213-6.
12. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000; 9: 283-92.
13. Barbui T, Finazzi G, Remuzzi A. Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology. Thromb Haemost 1995; 74: 511-4.